Type 2 diabetes is a long-term condition that affects how the body uses sugar for energy.
When blood sugar levels stay too high for too long, it can lead to serious health problems, including heart disease, kidney damage, and vision loss. Because of this, keeping blood sugar levels under control is one of the most important goals for people living with diabetes.
Doctors usually start treatment with a medicine called metformin. It is widely used because it is safe, affordable, and works well for many people.
However, over time, metformin alone is often not enough. Many patients need a second medicine to help keep their blood sugar at a healthy level. This raises an important question: which additional medicine works best?
To answer this, researchers from a large project called the GRADE Study carried out a major clinical trial. Their goal was to compare four commonly used diabetes drugs and see how well they worked when added to metformin.
The study included 5,047 adults with type 2 diabetes. These participants came from different racial and ethnic backgrounds, making the results more reliable and useful for a wide range of people. All of them were already taking metformin when they joined the study.
The researchers divided the participants into four groups. Each group received one additional medication. The four drugs tested were sitagliptin, liraglutide, glimepiride, and insulin glargine U-100. These medicines help lower blood sugar in different ways. Some help the body produce more insulin, while others provide insulin directly.
The study lasted for about four years. During this time, the researchers closely tracked how well each treatment helped people keep their blood sugar within the recommended range.
The results showed clear differences between the drugs. People who took liraglutide or insulin glargine along with metformin were able to keep their blood sugar under control for the longest time.
On average, they maintained good control for about six months longer than those taking sitagliptin, which was the least effective option. Glimepiride worked slightly better than sitagliptin, but it still did not perform as well as liraglutide or insulin glargine.
One important finding was that these results were similar for all types of participants. Age, sex, race, and ethnicity did not seem to change how well the drugs worked. This suggests that the findings can apply to many different people with type 2 diabetes.
However, the study also revealed a major challenge. Even with these treatments, nearly 75% of participants could not keep their blood sugar at the target level over the full four years. This shows how difficult it can be to manage diabetes over the long term, even with modern medicines.
The researchers also looked at heart health, which is a major concern for people with diabetes. Heart disease is one of the leading causes of illness and death in this group.
Among the four treatments, liraglutide stood out. People taking this drug were less likely to develop heart-related problems during the study. This added benefit makes liraglutide especially interesting for patients who are at risk of heart disease.
Even though liraglutide and insulin glargine performed better overall, the study did not find a perfect solution. Each medication has its own strengths and limits. This means doctors still need to choose treatments based on each person’s needs, health history, and preferences.
The study provides important guidance for both doctors and patients. It helps show which medicines may offer better long-term control when metformin alone is not enough. At the same time, it highlights the need for better treatments and strategies in the future.
The research was published in The New England Journal of Medicine and was led by Dr. Henry Burch and his team. Their work adds valuable knowledge to the ongoing effort to improve diabetes care.
For people living with diabetes, staying informed about new research can make a real difference. Understanding treatment options can help them work with their doctors to choose the best plan for their health and reduce the risk of serious complications over time.
If you care about diabetes, please read studies about a cure for type 2 diabetes, and these vegetables could protect against kidney damage in diabetes.
For more health information, please see recent studies about bone drug that could lower risk of type 2 diabetes, and results showing eating more eggs linked to higher risk of type 2 diabetes.
Copyright © 2026 Knowridge Science Report. All rights reserved.
